SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-094589
Filing Date
2021-03-25
Accepted
2021-03-25 17:02:00
Documents
3
Period of Report
2021-03-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d160344d8k.htm 8-K 17680
2 EX-99.1 d160344dex991.htm EX-99.1 56312
3 GRAPHIC g160344g44u21.jpg GRAPHIC 4639
  Complete submission text file 0001193125-21-094589.txt   81705
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39041 | Film No.: 21773158
SIC: 2834 Pharmaceutical Preparations